Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 149

1.

Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial.

Brahmer JR, Rodríguez-Abreu D, Robinson AG, Hui R, Csőszi T, Fülöp A, Gottfried M, Peled N, Tafreshi A, Cuffe S, O'Brien M, Rao S, Hotta K, Zhang J, Lubiniecki GM, Deitz AC, Rangwala R, Reck M.

Lancet Oncol. 2017 Dec;18(12):1600-1609. doi: 10.1016/S1470-2045(17)30690-3. Epub 2017 Nov 9.

PMID:
29129441
2.

Palliative Chemotherapy for Bladder Cancer: Treatment Delivery and Outcomes in the General Population.

Robinson AG, Wei X, Vera-Badillo FE, Mackillop WJ, Booth CM.

Clin Genitourin Cancer. 2017 Aug;15(4):e535-e541. doi: 10.1016/j.clgc.2016.12.025. Epub 2016 Dec 29.

PMID:
28117134
3.

Extending standard testing period in honeybees to predict lifespan impacts of pesticides and heavy metals using dynamic energy budget modelling.

Hesketh H, Lahive E, Horton AA, Robinson AG, Svendsen C, Rortais A, Dorne JL, Baas J, Spurgeon DJ, Heard MS.

Sci Rep. 2016 Dec 20;6:37655. doi: 10.1038/srep37655.

4.

Comparative toxicity of pesticides and environmental contaminants in bees: Are honey bees a useful proxy for wild bee species?

Heard MS, Baas J, Dorne JL, Lahive E, Robinson AG, Rortais A, Spurgeon DJ, Svendsen C, Hesketh H.

Sci Total Environ. 2017 Feb 1;578:357-365. doi: 10.1016/j.scitotenv.2016.10.180. Epub 2016 Nov 12.

PMID:
27847190
5.

Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.

Reck M, Rodríguez-Abreu D, Robinson AG, Hui R, Csőszi T, Fülöp A, Gottfried M, Peled N, Tafreshi A, Cuffe S, O'Brien M, Rao S, Hotta K, Leiby MA, Lubiniecki GM, Shentu Y, Rangwala R, Brahmer JR; KEYNOTE-024 Investigators.

N Engl J Med. 2016 Nov 10;375(19):1823-1833. Epub 2016 Oct 8.

6.

Clinical benefit of midodrine hydrochloride in symptomatic orthostatic hypotension: a phase 4, double-blind, placebo-controlled, randomized, tilt-table study.

Smith W, Wan H, Much D, Robinson AG, Martin P.

Clin Auton Res. 2016 Aug;26(4):269-77. doi: 10.1007/s10286-016-0363-9. Epub 2016 Jul 2.

7.

Use of Palliative Chemotherapy for Advanced Bladder Cancer: Patterns of Care in Routine Clinical Practice.

Robinson AG, Wei X, Mackillop WJ, Peng Y, Booth CM.

J Natl Compr Canc Netw. 2016 Mar;14(3):291-8.

PMID:
26957615
8.

Reasons for palliative treatments in stage III non-small-cell lung cancer: what contribution is made by time-dependent changes in tumour or patient status?

Robinson AG, Young K, Balchin K, Owen T, Ashworth A.

Curr Oncol. 2015 Dec;22(6):399-404. doi: 10.3747/co.22.2689.

9.

The function and regulation of the GATA factor ELT-2 in the C. elegans endoderm.

Wiesenfahrt T, Berg JY, Osborne Nishimura E, Robinson AG, Goszczynski B, Lieb JD, McGhee JD.

Development. 2016 Feb 1;143(3):483-91. doi: 10.1242/dev.130914. Epub 2015 Dec 23.

10.

Causes of death and subsequent treatment after initial radical or palliative therapy of stage III non-small-cell lung cancer.

Robinson AG, Young K, Balchin K, Ashworth A, Owen T.

Curr Oncol. 2015 Oct;22(5):333-40. doi: 10.3747/co.22.2432.

11.

Genetic influences on social attention in free-ranging rhesus macaques.

Watson KK, Li D, Brent LJ, Horvath JE, Gonzalez-Martinez J, Lambides RA, Robinson AG, Skene JH, Platt ML.

Anim Behav. 2015 May 1;103:267-275.

12.

The Role of Population-Based Observational Research in Bladder Cancer.

Robinson AG, Izard JP, Booth CM.

Bladder Cancer. 2015 Oct 26;1(2):123-131. Review.

13.

Progression-free survival as an end-point in solid tumours--perspectives from clinical trials and clinical practice.

Robinson AG, Booth CM, Eisenhauer EA.

Eur J Cancer. 2014 Sep;50(13):2303-8. doi: 10.1016/j.ejca.2014.05.024. Epub 2014 Jun 25. Review.

PMID:
24974171
14.

Disease-free survival as an end-point in the treatment of solid tumours--perspectives from clinical trials and clinical practice.

Robinson AG, Booth CM, Eisenhauer EA.

Eur J Cancer. 2014 Sep;50(13):2298-302. doi: 10.1016/j.ejca.2014.05.016. Epub 2014 Jun 12. Review.

PMID:
24930623
15.

Teaching and learning in medicine.

Robinson AG.

Pharos Alpha Omega Alpha Honor Med Soc. 2014 Winter;77(1):2-7. No abstract available.

PMID:
24620501
16.

Genetic origins of social networks in rhesus macaques.

Brent LJ, Heilbronner SR, Horvath JE, Gonzalez-Martinez J, Ruiz-Lambides A, Robinson AG, Skene JH, Platt ML.

Sci Rep. 2013;3:1042. doi: 10.1038/srep01042. Epub 2013 Jan 9.

17.

Magnetic resonance imaging in a patient with a dual chamber pacemaker.

Millar LM, Robinson AG, O'Flaherty MT, Eames N, Johnston N, Heyburn G.

Case Rep Med. 2010;2010:292071. doi: 10.1155/2010/292071. Epub 2011 Feb 6.

18.

Importance of testing for usability when selecting and implementing an electronic health or medical record system.

Corrao NJ, Robinson AG, Swiernik MA, Naeim A.

J Oncol Pract. 2010 May;6(3):120-4. doi: 10.1200/JOP.200017.

19.

HIV and hepatocellular and esophageal carcinomas related to consumption of mycotoxin-prone foods in sub-Saharan Africa.

Williams JH, Grubb JA, Davis JW, Wang JS, Jolly PE, Ankrah NA, Ellis WO, Afriyie-Gyawu E, Johnson NM, Robinson AG, Phillips TD.

Am J Clin Nutr. 2010 Jul;92(1):154-60. doi: 10.3945/ajcn.2009.28761. Epub 2010 May 19.

PMID:
20484447
20.

RBM5 as a putative tumor suppressor gene for lung cancer.

Sutherland LC, Wang K, Robinson AG.

J Thorac Oncol. 2010 Mar;5(3):294-8. doi: 10.1097/JTO.0b013e3181c6e330. Review.

21.

Open source tools in support of a multi-center prospective biomarker study in prostate cancer.

Dennis RA, Encarnacion R, Helsley A, Hong S, Huang K, Robinson AG.

AMIA Annu Symp Proc. 2007 Oct 11:930.

PMID:
18694030
22.

The Central Codebook (CCB) at the David Geffen School of Medicine at UCLA.

Dennis RA, Wang J, Huang K, Helsley A, Robinson AG.

AMIA Annu Symp Proc. 2006:908.

23.

Molecular predictive factors in patients receiving trastuzumab-based chemotherapy for metastatic disease.

Robinson AG, Turbin D, Thomson T, Yorida E, Ellard S, Bajdik C, Huntsman D, Gelmon K.

Clin Breast Cancer. 2006 Aug;7(3):254-61.

PMID:
16942643
24.

Using fresh tissue dissection to teach human anatomy in the clinical years.

Robinson AG, Metten S, Guiton G, Berek J.

Acad Med. 2004 Jul;79(7):711-6.

PMID:
15234927
25.

Valve surgery in octogenarians.

Ralph-Edwards AC, Robinson AG, Gordon RS, Ivanov J.

Can J Cardiol. 1999 Oct;15(10):1113-9.

PMID:
10523478
26.

Diabetes insipidus.

Robinson AG, Verbalis JG.

Curr Ther Endocrinol Metab. 1997;6:1-7. Review. No abstract available.

PMID:
9174688
27.

The central oxytocin pulse generator: a pacemaker for the ovarian cycle.

McCracken JA, Custer EE, Eldering JA, Robinson AG.

Acta Neurobiol Exp (Wars). 1996;56(3):819-32.

28.

The central oxytocin pulse generator: a pacemaker for luteolysis.

McCracken JA, Custer EE, Lamsa JC, Robinson AG.

Adv Exp Med Biol. 1995;395:133-54.

PMID:
8713960
29.

Control of posterior pituitary vasopressin content: implications for the regulation of the vasopressin gene.

Fitzsimmons MD, Roberts MM, Robinson AG.

Endocrinology. 1994 Apr;134(4):1874-8.

PMID:
8137755
30.

Diabetes insipidus.

Robinson AG, Verbalis JG.

Curr Ther Endocrinol Metab. 1994;5:1-6. No abstract available.

PMID:
7704688
31.

The diagnosis and management of diabetes insipidus during medical emergencies.

Buonocore CM, Robinson AG.

Endocrinol Metab Clin North Am. 1993 Jun;22(2):411-23. Review.

PMID:
8325295
32.

Vasopressin homeostasis: coordination of synthesis, storage and release.

Robinson AG, Fitzsimmons MD.

Regul Pept. 1993 Apr 29;45(1-2):225-30. Review. No abstract available.

PMID:
8511347
33.

c-fos expression in vasopressin and oxytocin neurons reveals functional heterogeneity within magnocellular neurons.

Roberts MM, Robinson AG, Fitzsimmons MD, Grant F, Lee WS, Hoffman GE.

Neuroendocrinology. 1993 Mar;57(3):388-400.

PMID:
8321410
34.

c-Fos and Fos-related antigens as markers for neuronal activity: perspectives from neuroendocrine systems.

Hoffman GE, Lee WS, Smith MS, Abbud R, Roberts MM, Robinson AG, Verbalis JG.

NIDA Res Monogr. 1993;125:117-33. Review. No abstract available.

PMID:
8341361
35.

Transient hyponatremia after damage to the neurohypophyseal tracts.

Ultmann MC, Hoffman GE, Nelson PB, Robinson AG.

Neuroendocrinology. 1992 Dec;56(6):803-11.

PMID:
1369588
36.

Models of neurohypophyseal homeostasis.

Fitzsimmons MD, Roberts MM, Sherman TG, Robinson AG.

Am J Physiol. 1992 Jun;262(6 Pt 2):R1121-30.

PMID:
1621868
37.

Cholecystokinin activates C-fos expression in hypothalamic oxytocin and corticotropin-releasing hormone neurons.

Verbalis JG, Stricker EM, Robinson AG, Hoffman GE.

J Neuroendocrinol. 1991 Apr 1;3(2):205-13. doi: 10.1111/j.1365-2826.1991.tb00264.x.

PMID:
19215523
38.

Vasopressin transport regulation is coupled to the synthesis rate.

Roberts MM, Robinson AG, Hoffman GE, Fitzsimmons MD.

Neuroendocrinology. 1991 Apr;53(4):416-22.

PMID:
2046874
39.

"Non-sweet" diabetes of pregnancy.

Robinson AG, Amico JA.

N Engl J Med. 1991 Feb 21;324(8):556-8. No abstract available.

PMID:
1992310
40.
41.

Hyponatremia in rats induces downregulation of vasopressin synthesis.

Robinson AG, Roberts MM, Evron WA, Verbalis JG, Sherman TG.

J Clin Invest. 1990 Oct;86(4):1023-9.

42.

Total translation of vasopressin and oxytocin in neurohypophysis of rats.

Robinson AG, Roberts MM, Evron WA, Janocko LE, Hoffman GE.

Am J Physiol. 1989 Jul;257(1 Pt 2):R109-17.

PMID:
2750955
43.

Changes in the metabolic clearance of vasopressin and in plasma vasopressinase throughout human pregnancy.

Davison JM, Sheills EA, Barron WM, Robinson AG, Lindheimer MD.

J Clin Invest. 1989 Apr;83(4):1313-8.

44.

Endocrine function in patients with large pituitary tumors treated with operative decompression and radiation therapy.

Nelson PB, Goodman ML, Flickenger JC, Richardson DW, Robinson AG.

Neurosurgery. 1989 Mar;24(3):398-400.

PMID:
2927614
45.

Hyponatremia in a Marathoner.

Nelson PB, Robinson AG, Kapoor W, Rinaldo J.

Phys Sportsmed. 1988 Oct;16(10):78-87. doi: 10.1080/00913847.1988.11709624.

PMID:
27451841
47.

Stereotaxic intracavitary irradiation for cystic craniopharyngiomas.

Pollack IF, Lunsford LD, Slamovits TL, Gumerman LW, Levine G, Robinson AG.

J Neurosurg. 1988 Feb;68(2):227-33.

PMID:
3276836
48.

Arginine vasotocin and a novel oxytocin-vasotocin-like material in plasma of human newborns.

Ervin MG, Amico JA, Leake RD, Ross MG, Robinson AG, Fisher DA.

Biol Neonate. 1988;53(1):17-22.

PMID:
3355867
49.

Effect of protein intake and urea on sodium excretion during inappropriate antidiuresis in rats.

Verbalis JG, Baldwin EF, Neish PN, Robinson AG.

Metabolism. 1988 Jan;37(1):46-54.

PMID:
3336285
50.

Metastatic tumor of the pituitary gland.

Nelson PB, Robinson AG, Martinez AJ.

Neurosurgery. 1987 Dec;21(6):941-4.

PMID:
3437967

Supplemental Content

Loading ...
Support Center